Health and Healthcare
Major Biotechs Have Short Sellers Excited
Published:
Last Updated:
The short interest data are out for the most recent settlement date, December 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big potential downside.
As we have said before, FDA rulings can make or break the biotech stocks, and short sellers and mega-bulls often go to war against each other in these companies. After all, if a single failed clinical trial can mean disaster for a stock, then some short sellers can argue for a stock implosion down the road.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The December 31 short interest data has been compared with the previous report, and short interest in all these selected biotech stocks increased.
Amgen Inc. (NASDAQ: AMGN) saw its short interest increase to 9.91 million shares from the previous level of 9.16 million. Shares were last seen trading at $238.26, in a 52-week range of $166.30 to $244.99.
Short interest in Biogen Inc. (NASDAQ: BIIB) grow to 4.33 million shares from the previous 4.19 million. The stock recently traded at $296.51, within a 52-week range of $215.78 to $344.00.
Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest rise to 21.30 million shares from 16.04 million in the previous period. Shares were trading at $65.03, in a 52-week range of $60.89 to $70.50.
The number of MannKind Corp. (NASDAQ: MNKD) shares short increased to 40.29 million. The previous reading was 39.82 million. The stock traded at $1.51 a share, in a 52-week range of $1.02 to $2.34.
Alexion Pharmaceuticals Inc.’s (NASDAQ: ALXN) short interest rise to 4.66 million shares from the previous 4.46 million. Shares were trading at $109.48, in a 52-week range of $94.59 to $141.86.
The Average American Is Losing Momentum On Their Savings Every Day (Sponsor)
If you’re like many Americans and keep your money ‘safe’ in a checking or savings account, think again. The average yield on a savings account is a paltry .4%1 today. Checking accounts are even worse.
But there is good news. To win qualified customers, some accounts are paying more than 7x the national average. That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 4.00% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.
Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.